Accelerating virtual clinical trials
By Medidata, a Dassault Systèmes company The pandemic drove 45% of clinical trial sites to transition patients from in-person to remote visits using virtual trial solutions.¹ An astounding 83% of all clinical trials are now partially or entirely virtualized,¹ with components taking place and being managed from outside the traditional trial site setting. While adopting new virtualization technologies introduces new challenges and learning curves, it also creates significant opportunities for all stakeholders. In fact, an estimated 97% of biopharma executives intend to leverage digital tec...
Source: biopharmadive.com